Signaling Pathways - F1 Fo-ATPase - LRRK2 - Glucagon-like peptide 1 (GLP-1) receptors - EGFR
清除全部
- B5889 EGF8162 Citation中文名: 那扎替尼Target: EGFRSummary: EGFR突变选择性抑制剂
- B5836 AZ5104Target: EGFRSummary: EGFR抑制剂
- B6943 Exendin-3 (9-39) amide1 CitationTarget: Glucagon-like peptide 1 (GLP-1) receptorsSummary: GLP-1受体拮抗剂
- B4635 CZC-25146Target: LRRK2Summary: LRRK2抑制剂
- B4633 GNE0877Target: LRRK2Summary: LRRK2抑制剂
- B3605 GNE-7915Target: LRRK2Summary: LRRK2抑制剂
- B1104 AZD-92911 Citation中文名: 奥希替尼Target: EGFRSummary: 突变型EGFR抑制剂。
- B1262 HG-10-102-011 CitationTarget: LRRK2Summary: LRRK2抑制剂
- B3041 BTB06584Target: F1 Fo-ATPaseSummary: F1F0 ATP合酶抑制剂
- A8555 Vandetanib (ZD6474)中文名: 凡德他尼Target: VEGFR|EGFRSummary: VEGFR2/EGFR拮抗剂